- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 255/24 - Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
Patent holdings for IPC class C07C 255/24
Total number of patents in this class: 78
10-year publication summary
1
|
7
|
9
|
3
|
6
|
0
|
4
|
7
|
6
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Acuitas Therapeutics Inc. | 117 |
10 |
Modernatx, Inc. | 1284 |
10 |
BASF SE | 20979 |
7 |
Ascend Performance Materials Operations LLC | 274 |
3 |
Cansino Biologics Inc. | 75 |
3 |
DuPont Electronic Materials International, LLC | 429 |
3 |
Rhodia Operations | 1587 |
2 |
Vivace Therapeutics, Inc. | 30 |
2 |
The Procter & Gamble Company | 22000 |
1 |
Bristol-myers Squibb Company | 4867 |
1 |
Hoffmann-La Roche Inc. | 3461 |
1 |
Pfizer Inc. | 3368 |
1 |
Merck Patent GmbH | 5824 |
1 |
Dow Global Technologies LLC | 10402 |
1 |
Showa Denko K.K. | 2204 |
1 |
The Trustees of the University of Pennsylvania | 4337 |
1 |
Astellas Pharma Inc. | 1083 |
1 |
BioAmber S.A.S. | 20 |
1 |
Bose Institute | 4 |
1 |
Clariant International Ltd. | 933 |
1 |
Other owners | 26 |